A Profile of the Biomedical Materials Industry (PDF format)
The search for innovation
This report examines how 50 biomedical materials companies are developing in the expanding biomedical materials industry.
Published by International Newsletters and written by Paula Read, the publication will help you to understand and follow the rapid pace of industry restructuring and consolidation; identify future business opportunities fuelled by greater demand and expectations; monitor your competition and assess the risks involved in investing in this sector (e.g. damaging litigation, product recalls, products containing materials derived from animal sources).
Published March 2012
PDF format (single user licence)
Extensive and up-to-date coverage
This comprehensive report includes the most up-to-date coverage of mergers, acquisitions and joint ventures in the sector and analysis of all the latest published financial data from the companies profiled, complete with full contact details including names of key executives.
It will give you an invaluable insight into the corporate strategies employed by the major companies, the risks they face and new opportunities to be exploited in the future.
The report is essential reading if you need to understand the development and prospects for the biomedical materials sector whether you are a supplier, a manufacturer, an end-user, a consultant, a financial analyst or investor interested in the biomedical materials sector.
The biomedical materials industry
Each company has been included in the report owing not only to its financial success, but also on the role it plays in the industry. Some of the companies included are highly diversified with interests in many areas, but their contribution to the biomaterials sector is still significant. Other medium-sized or smaller companies are included because of their focus on a particular area of biomaterials. A selection of medical device producers has also been included because of their involvement in developing biomaterials for applications in their own products.
The science of biomaterials is relatively new. Its development over the past 50 years has been continual, attracting many companies able and eager to make large investments in the sector. The pursuit of longer, better lives has created a fertile environment for products that enhance, protect and repair our bodies. The biomedical industry, while it still faces the same economic challenges and cyclical patterns of demand that face any business, is central to this growth market.
The following companies are included in the report:
Alphatec Spine (Alphatec Holdings)
ATI Allegheny Ludlum
Bayer Material Science
DSM Biomedical (Royal DSM)
WL Gore & Associates
Johnson & Johnson: subsidiaries Ethicon, Synthes
Olympus Terumo Biomaterials
PolyMedex Discovery Group
Solvay Advanced Polymers
Smith & Nephew
3DMJ (Japan) and 3DM (USA)